Skip to main content

NANOESTRUCTURAS PARA IMAGEN, DETECCION Y CALENTAMIENTO MAGNETICO DE CELULAS TUMORALES

PID2019-106301RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NANOCIENCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tunable control of the structural features and related physical properties of MnxFe3- xO4 nanoparticles: Implication on their heating performance by magnetic hyperthermia

  • Del Sol-Fernández, Susel
  • Odio, Oscar F.
  • Crespo, Paula M.
  • Obed Pérez, E.
  • Salas, Gorka
  • Gutiérrez, Lucía
  • Morales, María Del Puerto
  • Reguera, Edilso
Four different manganese ferrite (MnxFe3–xO4) nanostructures (9 and 15 nm spheres (S1, S2), 18 nm nanoflowers (NFs), and 20 nm cubes (NC)) were prepared in this work through a thermal decomposition method by tuning the critical synthetic parameters. In all of the prepared materials, the cation composition of the ferrite phase was rather similar. The occurrence of a secondary phase of mangano-wüstite within MnxFe3–xO4 nanoparticles and its impact on the magnetic properties were studied in detail from static and dynamic magnetic measurements complemented with Mössbauer spectroscopy, X-ray diffraction, high-resolution transmission electron microscopy (HRTEM) analysis, and X-ray photoelectron spectroscopy (XPS). All of the computed data were consistent with a deterioration of the magnetic output as the reduced phase becomes progressively important, leading to a marked spin disorder and the reduction of either the effective magnetic size or the saturation magnetization. The heating efficiency was measured from 100 up to 300 kHz and from 8 up to 24 kA/m, the NF sample being the one displaying the highest specific absorption rate (SAR) under all tested conditions. These results agreed with the physicochemical and magnetic characterization of the particles, highlighting the interest of the detailed characterization of the particles to understand their heating properties relevant for biomedical applications and others such as catalysis., S.D.S.F. acknowledges the economic support by CONACyT and Instituto Politécnico Nacional SIP 20180252 (México). The authors thank the Laboratorio Nacional de Conversión y Almacenamiento de Energía (LNCAE) for access to its experimental facility. This research was partially funded by the Spanish Ministry of Economy and Competitiveness under grant MAT2017-88148-R (AEI/FEDER, UE) and by the Spanish Ministry of Science, Innovation and Universities (MCIU) through projects PGC2018-096016-B-I00 (MCIU/AEI/FEDER to L.G.) and PID2019-106301RB-I00 (G.S.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Iron oxide-manganese oxide nanoparticles with tunable morphology and switchable MRI contrast mode triggered by intracellular conditions

  • García-Soriano, David
  • Milán-Rois, Paula
  • Lafuente-Gómez, Nuria
  • Navío, Cristina
  • Gutiérrez, Lucía
  • Cussó, Lorena
  • Desco, Manuel
  • Calle, Daniel
  • Somoza, Álvaro
  • Salas, Gorka
Stimuli-responsive nanomaterials are very attractive for biomedical applications. They can be activated through external stimuli or by the physico-chemical conditions present in cells or tissues. Here, we describe the preparation of hybrid iron oxide-manganese oxide core-satellite shell nanostructures that change their contrast mode in magnetic resonance imaging (MRI) from T2 to T1, after being internalized by cells. This occurs by the dissolution of the MnO2 of the shell, preserving intact the iron oxide at the core. First, we study the seeded-growth synthesis of iron oxide-manganese oxide nanoparticles studying the effect of varying the core size of the magnetic seeds and the concentration of the surfactant. This allows tuning the size and shape of the final hybrid nanostructure. Then, we show that the shell can be removed by a redox reaction with glutathione, which is naturally present inside the cells at much higher concentrations than outside the cells. Finally, the dissolution of the MnO2 shell and the change in the contrast mode is confirmed in cell cultures. After this process, the iron oxide nanoparticles at the core remain intact and are still active as heating mediators when an alternating magnetic field is applied., This work was supported by the Ministerio de Ciencia e Innovación (PID2019-106301RB-I00 to GS and PGC2018-096016-B-I00 to L.G.), Instituto de Salud Carlos III (PT20/00044; co‐funded by European Union, European Regional Development Fund, ERDF, “A way of making Europe”), Ministerio de Economía y Competitividad (SAF2017-87305-R), Comunidad de Madrid (fellowships PEJD-2016/IND-2293 and IND2017/IND-7809; projects B2017/BMD-3867; P2018/NMT-4321), European Commission H2020 programme (project NOCANTHER, grant agreement no. 685795), and Asociación Española Contra el Cáncer. IMDEA Nanociencia acknowledges support from the 'Severo Ochoa' Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation. L.G. acknowledges financial support from the Ramón y Cajal program (RYC-2014-15512). N. L-G also thanks the Spanish Education Ministry for the funding (FPU18/02323). P. M-R- acknowledges the support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multifunctional magnetic nanoparticles elicit anti-tumor immunity in a mouse melanoma model

  • Lafuente-Gómez, Nuria
  • de Lázaro, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Sobral, Miguel C.
  • Salas, Gorka
  • Mooney, David J.
  • Somoza, Álvaro
Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2023.100817, Immunotherapy has emerged as a promising strategy to eradicate cancer cells. Particularly, the development of cancer vaccines to induce a potent and sustained antigen-specific T cell response has become a center of attention. Herein, we describe a novel immunotherapy based on magnetic nanoparticles (MNP) covalently modified with the OVA254-267 antigen and a CpG oligonucleotide via disulfide bonds. The MNP-CpG-COVA significantly enhances dendritic cell activation and CD8+ T cell antitumoral response against B16-OVA melanoma cells in vitro. Notably, the immune response induced by the covalently modified MNP is more potent and sustained over time than that triggered by the free components, highlighting the advantage of nanoformulations in immunotherapies. What is more, the nanoparticles are stable in the blood after in vivo administration and induce potent levels of systemic tumor-specific effector CD8 + T cells. Overall, our findings highlight the potential of covalently functionalized MNP to induce robust immune responses against mouse melanoma., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cancer, and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez also thanks the Spanish Education Ministry [FPU18/02323], the Spanish Ministry of Universities [EST21/00504], and CRIS Cancer Foundation [Outback2022_14, cofinanced by Fundación ADEY] for the funding.Irene de Lázaro was supported by the National Cancer Institute of the National Institutes of Health under award no. U01CA214369. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Consultation and processing of samples for TEM studies were performed at the Electron Microscopy Facility of the Harvard Medical School., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multicore iron oxide nanoparticles for magnetic hyperthermia and combination therapy against cancer cells

  • García-Soriano, David
  • Milán-Rois, Paula
  • Lafuente-Gómez, Nuria
  • Rodríguez-Díaz, Ciro
  • Navío, Cristina
  • Somoza, Álvaro
  • Salas, Gorka
Multicore flower-like iron oxide nanoparticles (IONPs) are among the best candidates for magnetic hyperthermia applications against cancers. However, they are rarely investigated in physiological environments and their efficacy against cancer cells has been even less studied. The combination of magnetic hyperthermia, using multicore IONPs, with selected bioactive molecules should lead to an enhanced activity against cancer cells., This work was supported by the Ministerio de Ciencia e Innovación (PID2019-106301RB-I00 and PID2020-119352RB-I00) and Comunidad de Madrid (S2022/BMD-7403 RENIM-CM). PMR and NLG acknowledge Ministerio de Economía y Competitividad and Ministerio de Ciencia (BES-2017-082521 and FPU18/02323 fellowships). IMDEA Nanociencia acknowledges support from the ’Severo Ochoa’ Programme for Centres of Excellence (Ministerio de Ciencia e Innovación, CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer

  • Lafuente-Gómez, Nuria
  • Martínez-Mingo, Mario
  • Díaz-Riascos, Zamira Vanessa
  • García-Prats, Belén
  • de la Iglesia, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Campos, Luis A
  • Mancilla-Zamora, Sandra
  • Salas, Gorka
  • Abasolo, Ibane
  • Somoza, Álvaro
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jconrel.2025.113791., Pancreatic ductal adenocarcinoma is a highly aggressive cancer with a low survival rate. Thus, efforts are needed to develop more effective treatments. Herein, we propose utilizing magnetic nanoparticles (MNP) for the concurrent delivery of gemcitabine and miRNA34a mimic to target pancreatic cancer cells. The MNP were functionalized with disulfide bonds to selectively release their cargo inside tumor cells. The incorporation of the miRNA34a mimic increased the sensitivity of cells to gemcitabine, especially in BxPC-3 cells. Additionally, the miRNA34a sequence was modified with locked nucleic acids (LNA) to increase stability. The resulting LNA34a showed a stronger cytotoxic effect when combined with gemcitabine, even in PANC-1 cells, which are resistant to the drug. Notably, the modified MNP exhibited less toxicity than their free counterparts when incubated with HaCaT cells, a model of healthy keratinocytes. Additionally, the combined delivery of miRNA34a mimics and gemcitabine using MNP elicited a synergistic cytotoxic effect against pancreatic cancer cells through magnetic hyperthermia. The intratumoral administration of the modified MNP in subcutaneous xenografts of BxPC-3 cells resulted in a sustained increase in temperature when an alternating magnetic field was applied. Notably, the treatment with the MNP functionalized with GEM and LNA34a led to significant changes in the expression of NOTCH1 and NOTCH2 in the tumor, which are direct targets of miRNA34a, as well as HSP70, which is related to the cellular response to stressors like heat., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2023-146982OB-I00, PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cáncer [PRYCO223002PEIN], and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher) and No 814607 (Safe-n-Medtech). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez and Mario Martínez-Mingo thankSpanish Science Ministry [FPU18/02323, FJC2021-048151-I, respectively] for the funding., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation

  • Luengo, Yurena
  • Díaz Riascos, Zamira Vanessa|||0000-0003-1595-618X
  • García-Soriano, David
  • Teran, Francisco J.
  • Artés-Ibáñez, Emilio J.
  • Ibarrola, Oihane|||0000-0002-9089-6925
  • Somoza, Álvaro
  • Miranda, Rodolfo
  • Schwartz, Simon|||0000-0001-8297-7971
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Salas, Gorka
The clinical implementation of magnetic hyperthermia has experienced little progress since the first clinical trial was completed in 2005. Some of the hurdles to overcome are the reliable production of magnetic nanoparticles with controlled properties and the control of the temperature at the target tissue in vivo. Here, forty samples of iron oxide superparamagnetic nanoparticles were prepared by similar methods and thoroughly characterized in terms of size, aggregation degree, and heating response. Selected samples were intratumorally administered in animals with subcutaneous xenografts of human pancreatic cancer. In vivo experiments showed that it is possible to control the rise in temperature by modulating the field intensity during in vivo magnetic hyperthermia protocols. The procedure does not require sophisticated materials and it can be easily implemented by researchers or practitioners working in magnetic hyperthermia therapies.